다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinical and molecular hepatology, v.18 no.4, 2012년, pp.337 - 346
Seo, Yeon Seok (Gastroenterology Research Unit, Mayo Clinic, Rochester, MN, USA.) , Shah, Vijay H. (Gastroenterology Research Unit, Mayo Clinic, Rochester, MN, USA.)
AI-Helper
Because of the anatomical position and its unique vascular system, the liver is susceptible to the exposure to the microbial products from the gut. Although large amount of microbes colonize in the gut, translocation of the microbes or microbial products into the liver and systemic circulation is pr...
1 Shah VJ Kamath PS Feldman M Fridman LS Brandt LJ Portal hypertension and gastrointestinal bleeding Sleisenger and Fordtran's gastrointestinal and liver disease 2010 9th ed Philadelphia PA Saunders Elsevier 1489 1516
2 Rao R Endotoxemia and gut barrier dysfunction in alcoholic liver disease Hepatology 2009 50 638 644 19575462
3 Seki E Brenner DA Toll-like receptors and adaptor molecules in liver disease: update Hepatology 2008 48 322 335 18506843
4 Rao RK Seth A Sheth P Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease Am J Physiol Gastrointest Liver Physiol 2004 286 G881 G884 15132946
5 Rao RK Acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer Alcohol Clin Exp Res 1998 22 1724 1730 9835287
6 Keshavarzian A Farhadi A Forsyth CB Rangan J Jakate S Shaikh M Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats J Hepatol 2009 50 538 547 19155080
7 Keshavarzian A Holmes EW Patel M Iber F Fields JZ Pethkar S Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage Am J Gastroenterol 1999 94 200 207 9934756
8 Yumuk Z Ozdemirci S Erden BF Dundar V The effect of long-term ethanol feeding on Brucella melitensis infection of rats Alcohol Alcohol 2001 36 314 317 11468131
9 Kavanaugh MJ Clark C Goto M Kovacs EJ Gamelli RL Sayeed MM Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function Burns 2005 31 290 296 15774282
10 Wheeler MD Kono H Yin M Nakagami M Uesugi T Arteel GE The role of Kupffer cell oxidant production in early ethanol-induced liver disease Free Radic Biol Med 2001 31 1544 1549 11744328
11 Thakur V McMullen MR Pritchard MT Nagy LE Regulation of macrophage activation in alcoholic liver disease J Gastroenterol Hepatol 2007 22 Suppl 1 S53 S56 17567466
12 Miele L Valenza V La Torre G Montalto M Cammarota G Ricci R Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 2009 49 1877 1887 19291785
13 Huang Y Blatt LM Taylor MW Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist J Interferon Cytokine Res 1995 15 317 321 7627806
14 Csak T Velayudham A Hritz I Petrasek J Levin I Lippai D Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice Am J Physiol Gastrointest Liver Physiol 2011 300 G433 G441 21233280
15 Bergheim I Weber S Vos M Krämer S Volynets V Kaserouni S Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin J Hepatol 2008 48 983 992 18395289
16 Farhadi A Gundlapalli S Shaikh M Frantzides C Harrell L Kwasny MM Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis Liver Int 2008 28 1026 1033 18397235
17 Bigatello LM Broitman SA Fattori L Di Paoli M Pontello M Bevilacqua G Endotoxemia, encephalopathy, and mortality in cirrhotic patients Am J Gastroenterol 1987 82 11 15 3799574
18 Lin RS Lee FY Lee SD Tsai YT Lin HC Lu RH Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation J Hepatol 1995 22 165 172 7790704
19 Michie HR Manogue KR Spriggs DR Revhaug A O'Dwyer S Dinarello CA Detection of circulating tumor necrosis factor after endotoxin administration N Engl J Med 1988 318 1481 1486 2835680
20 van Deventer SJ Büller HR ten Cate JW Aarden LA Hack CE Sturk A Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways Blood 1990 76 2520 2526 2124934
21 Mathison JC Ulevitch RJ The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits J Immunol 1979 123 2133 2143 489976
22 Zlydaszyk JC Moon RJ Fate of 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice Infect Immun 1976 14 100 105 780270
23 Lumsden AB Henderson JM Kutner MH Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis Hepatology 1988 8 232 236 3281884
24 Szabo G Bala S Petrasek J Gattu A Gut-liver axis and sensing microbes Dig Dis 2010 28 737 744 21525758
25 Artis D Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut Nat Rev Immunol 2008 8 411 420 18469830
26 Varol C Zigmond E Jung S Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria Nat Rev Immunol 2010 10 415 426 20498668
27 Varol C Vallon-Eberhard A Elinav E Aychek T Shapira Y Luche H Intestinal lamina propria dendritic cell subsets have different origin and functions Immunity 2009 31 502 512 19733097
28 Crispe IN The liver as a lymphoid organ Annu Rev Immunol 2009 27 147 163 19302037
29 Nakao A Taki S Yasui M Kimura Y Nonami T Harada A The fate of intravenously injected endotoxin in normal rats and in rats with liver failure Hepatology 1994 19 1251 1256 8175149
30 Catalá M Antón A Portolés MT Characterization of the simultaneous binding of Escherichia coli endotoxin to Kupffer and endothelial liver cells by flow cytometry Cytometry 1999 36 123 130 10554160
31 Dolganiuc A Norkina O Kodys K Catalano D Bakis G Marshall C Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection Gastroenterology 2007 133 1627 1636 17916356
32 Roth J McClellan JL Kluger MJ Zeisberger E Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea-pigs J Physiol 1994 477 177 185 8071885
33 Szabo G Mandrekar P Girouard L Catalano D Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production Alcohol Clin Exp Res 1996 20 900 907 8865966
34 McClain CJ Cohen DA Increased tumor necrosis factor production by monocytes in alcoholic hepatitis Hepatology 1989 9 349 351 2920991
35 Vreugdenhil AC Snoek AM van't Veer C Greve JW Buurman WA LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction J Clin Invest 2001 107 225 234 11160139
36 Medvedev AE Lentschat A Wahl LM Golenbock DT Vogel SN Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells J Immunol 2002 169 5209 5216 12391239
37 Garcia-Tsao G Wiest R Gut microflora in the pathogenesis of the complications of cirrhosis Best Pract Res Clin Gastroenterol 2004 18 353 372 15123075
38 Riordan SM Williams R Gut flora and hepatic encephalopathy in patients with cirrhosis N Engl J Med 2010 362 1140 1142 20335591
39 Berg RD Garlington AW Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model Infect Immun 1979 23 403 411 154474
40 Wiest R Garcia-Tsao G Bacterial translocation (BT) in cirrhosis Hepatology 2005 41 422 433 15723320
41 Pradere JP Troeger JS Dapito DH Mencin AA Schwabe RF Toll-like receptor 4 and hepatic fibrogenesis Semin Liver Dis 2010 30 232 244 20665376
42 Son G Kremer M Hines IN Contribution of gut bacteria to liver pathobiology Gastroenterol Res Pract 2010 2010 pii: 453563
43 Artis D Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut Nat Rev Immunol 2008 8 411 420 18469830
44 Bäckhed F Ley RE Sonnenburg JL Peterson DA Gordon JI Host-bacterial mutualism in the human intestine Science 2005 307 1915 1920 15790844
45 Rao RK Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer Methods Mol Biol 2008 447 171 183 18369919
46 Tang Y Forsyth CB Farhadi A Rangan J Jakate S Shaikh M Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage Alcohol Clin Exp Res 2009 33 1220 1230 19389191
47 Yajima S Morisaki H Serita R Suzuki T Katori N Asahara T Tumor necrosis factor-alpha mediates hyperglycemia-augmented gut barrier dysfunction in endotoxemia Crit Care Med 2009 37 1024 1030 19237913
48 Miettinen TA Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease Gut 1972 13 682 689 4118161
49 Sung JY Shaffer EA Costerton JW Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipids Dig Dis Sci 1993 38 2104 2112 8223087
50 Gunnarsdottir SA Sadik R Shev S Simrén M Sjövall H Stotzer PO Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension Am J Gastroenterol 2003 98 1362 1370 12818282
51 Van Thiel DH Fagiuoli S Wright HI Chien MC Gavaler JS Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment Hepatology 1994 19 67 71 8276369
52 Madrid AM Cumsille F Defilippi C Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease Dig Dis Sci 1997 42 738 742 9125642
53 Madrid AM Brahm J Buckel E Silva G Defilippi C Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients Am J Gastroenterol 1997 92 1044 1045 9177529
54 Robinson CJ Bohannan BJ Young VB From structure to function: the ecology of host-associated microbial communities Microbiol Mol Biol Rev 2010 74 453 476 20805407
55 Gillevet P Sikaroodi M Keshavarzian A Mutlu EA Quantitative assessment of the human gut microbiome using multitag pyrosequencing Chem Biodivers 2010 7 1065 1075 20491064
56 Zeuzem S Gut-liver axis Int J Colorectal Dis 2000 15 59 82 10855547
57 Norman K Pirlich M Gastrointestinal tract in liver disease: which organ is sick? Curr Opin Clin Nutr Metab Care 2008 11 613 619 18685458
58 Chen Y Yang F Lu H Wang B Chen Y Lei D Characterization of fecal microbial communities in patients with liver cirrhosis Hepatology 2011 54 562 572 21574172
59 Lu H Wu Z Xu W Yang J Chen Y Li L Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients Microb Ecol 2011 61 693 703 21286703
60 Gómez-Hurtado I Santacruz A Peiró G Zapater P Gutiérrez A Pérez-Mateo M Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis PLoS One 2011 6 e23037 21829583
61 Zhang W Gu Y Chen Y Deng H Chen L Chen S Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis Eur J Gastroenterol Hepatol 2010 22 1481 1486 20739895
62 Grangé JD Roulot D Pelletier G Pariente EA Denis J Ink O Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial J Hepatol 1998 29 430 436 9764990
63 Liu Q Duan ZP Ha DK Bengmark S Kurtovic J Riordan SM Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 2004 39 1441 1449 15122774
64 Novella M Solà R Soriano G Andreu M Gana J Ortiz J Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin Hepatology 1997 25 532 536 9049193
65 Rasaratnam B Kaye D Jennings G Dudley F Chin-Dusting J The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial Ann Intern Med 2003 139 186 193 12899586
66 Henao-Mejia J Elinav E Jin C Hao L Mehal WZ Strowig T Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 2012 482 179 185 22297845
67 Mandrekar P Bala S Catalano D Kodys K Szabo G The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes J Immunol 2009 183 1320 1327 19561104
68 Nagy LE Recent insights into the role of the innate immune system in the development of alcoholic liver disease Exp Biol Med (Maywood) 2003 228 882 890 12968059
69 Wu D Cederbaum AI Oxidative stress and alcoholic liver disease Semin Liver Dis 2009 29 141 154 19387914
70 Szabo G Mandrekar P Petrasek J Catalano D The unfolding web of innate immune dysregulation in alcoholic liver injury Alcohol Clin Exp Res 2011 35 782 786 21284666
71 Adachi Y Bradford BU Gao W Bojes HK Thurman RG Inactivation of Kupffer cells prevents early alcohol-induced liver injury Hepatology 1994 20 453 460 8045507
72 Adachi Y Moore LE Bradford BU Gao W Thurman RG Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 1995 108 218 224 7806045
73 van Rooijen N Sanders A van den Berg TK Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine J Immunol Methods 1996 193 93 99 8690935
74 Paik YH Schwabe RF Bataller R Russo MP Jobin C Brenner DA Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 2003 37 1043 1055 12717385
75 Karaa A Thompson KJ McKillop IH Clemens MG Schrum LW S-adenosyl-L-methionine attenuates oxidative stress and hepatic stellate cell activation in an ethanol-LPS-induced fibrotic rat model Shock 2008 30 197 205 18180699
76 Quiroz SC Bucio L Souza V Hernández E González E Gómez-Quiroz L Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde J Gastroenterol Hepatol 2001 16 1267 1273 11903746
77 Rock FL Hardiman G Timans JC Kastelein RA Bazan JF A family of human receptors structurally related to Drosophila Toll Proc Natl Acad Sci U S A 1998 95 588 593 9435236
78 Medzhitov R Preston-Hurlburt P Janeway CA Jr A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 1997 388 394 397 9237759
79 Guo J Friedman SL Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis Fibrogenesis Tissue Repair 2010 3 21 20964825
80 Szabo G Dolganiuc A Mandrekar P Pattern recognition receptors: a contemporary view on liver diseases Hepatology 2006 44 287 298 16871558
81 Takeuchi O Akira S Pattern recognition receptors and inflammation Cell 2010 140 805 820 20303872
82 Yamamoto M Takeda K Current views of toll-like receptor signaling pathways Gastroenterol Res Pract 2010 2010 240365 21197425
83 Poltorak A He X Smirnova I Liu MY Van Huffel C Du X Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 1998 282 2085 2088 9851930
84 Shimazu R Akashi S Ogata H Nagai Y Fukudome K Miyake K MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J Exp Med 1999 189 1777 1782 10359581
85 Wright SD Ramos RA Tobias PS Ulevitch RJ Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 1990 249 1431 1433 1698311
86 Mandrekar P Szabo G Signalling pathways in alcohol-induced liver inflammation J Hepatol 2009 50 1258 1266 19398236
87 Verstak B Nagpal K Bottomley SP Golenbock DT Hertzog PJ Mansell A MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses J Biol Chem 2009 284 24192 24203 19592497
88 Akira S Uematsu S Takeuchi O Pathogen recognition and innate immunity Cell 2006 124 783 801 16497588
89 Seki E Schnabl B Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut J Physiol 2012 590 447 458 22124143
90 Schafer SL Lin R Moore PA Hiscott J Pitha PM Regulation of type I interferon gene expression by interferon regulatory factor-3 J Biol Chem 1998 273 2714 2720 9446577
91 Hritz I Mandrekar P Velayudham A Catalano D Dolganiuc A Kodys K The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 Hepatology 2008 48 1224 1231 18792393
92 Rivera CA Adegboyega P van Rooijen N Tagalicud A Allman M Wallace M Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J Hepatol 2007 47 571 579 17644211
93 Chen GY Nuñez G Sterile inflammation: sensing and reacting to damage Nat Rev Immunol 2010 10 826 837 21088683
94 Martinon F Burns K Tschopp J The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 2002 10 417 426 12191486
95 Ye Z Ting JP NLR, the nucleotide-binding domain leucine-rich repeat containing gene family Curr Opin Immunol 2008 20 3 9 18280719
96 Bauernfeind F Ablasser A Bartok E Kim S Schmid-Burgk J Cavlar T Inflammasomes: current understanding and open questions Cell Mol Life Sci 2011 68 765 783 21072676
97 Sutterwala FS Ogura Y Flavell RA The inflammasome in pathogen recognition and inflammation J Leukoc Biol 2007 82 259 264 17470531
98 Martinon F Mayor A Tschopp J The inflammasomes: guardians of the body Annu Rev Immunol 2009 27 229 265 19302040
99 Agostini L Martinon F Burns K McDermott MF Hawkins PN Tschopp J NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 2004 20 319 325 15030775
100 Dinarello CA Immunological and inflammatory functions of the interleukin-1 family Annu Rev Immunol 2009 27 519 550 19302047
101 Bauernfeind F Bartok E Rieger A Franchi L Núñez G Hornung V Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome J Immunol 2011 187 613 617 21677136
102 Ganz M Csak T Nath B Szabo G Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver World J Gastroenterol 2011 17 4772 4778 22147977
103 McClain CJ Cohen DA Dinarello CA Cannon JG Shedlofsky SI Kaplan AM Serum interleukin-1 (IL-1) activity in alcoholic hepatitis Life Sci 1986 39 1479 1485 3490610
104 Valles SL Blanco AM Azorin I Guasch R Pascual M Gomez-Lechon MJ Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes Alcohol Clin Exp Res 2003 27 1979 1986 14691386
105 Bjarnason I Peters TJ Wise RJ The leaky gut of alcoholism: possible route of entry for toxic compounds Lancet 1984 1 179 182 6141332
106 Draper LR Gyure LA Hall JG Robertson D Effect of alcohol on the integrity of the intestinal epithelium Gut 1983 24 399 404 6840613
107 Parlesak A Schäfer C Schütz T Bode JC Bode C Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease J Hepatol 2000 32 742 747 10845660
108 Chesta J Defilippi C Abnormalities in proximal small bowel motility in patients with cirrhosis Hepatology 1993 17 828 832 8491451
109 Guarner C Runyon BA Young S Heck M Sheikh MY Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites J Hepatol 1997 26 1372 1378 9210626
110 Ramachandran A Prabhu R Thomas S Reddy JB Pulimood A Balasubramanian KA Intestinal mucosal alterations in experimental cirrhosis in the rat: role of oxygen free radicals Hepatology 2002 35 622 629 11870376
111 Rajkovic IA Williams R Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis Hepatology 1986 6 252 262 3007318
112 Garcia-Tsao G Lee FY Barden GE Cartun R West AB Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites Gastroenterology 1995 108 1835 1841 7768390
113 Gaeta GB Perna P Adinolfi LE Utili R Ruggiero G Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance Digestion 1982 23 239 244 6183161
114 Bode C Kugler V Bode JC Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess J Hepatol 1987 4 8 14 3571935
115 Urbaschek R McCuskey RS Rudi V Becker KP Stickel F Urbaschek B Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease Alcohol Clin Exp Res 2001 25 261 268 11236841
116 Harte AL da Silva NF Creely SJ McGee KC Billyard T Youssef-Elabd EM Elevated endotoxin levels in non-alcoholic fatty liver disease J Inflamm (Lond) 2010 7 15 20353583
117 Nanji AA Khettry U Sadrzadeh SM Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease) Proc Soc Exp Biol Med 1994 205 243 247 8171045
118 Schwabe RF Seki E Brenner DA Toll-like receptor signaling in the liver Gastroenterology 2006 5 130 6 1886 1900 16697751
119 Yang SQ Lin HZ Lane MD Clemens M Diehl AM Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Natl Acad Sci U S A 1997 94 2557 2562 9122234
120 Szabo G Velayudham A Romics L Jr Mandrekar P Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4 Alcohol Clin Exp Res 2005 29 11 Suppl 140S 145S 16344599
121 Solga SF Diehl AM Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics J Hepatol 2003 38 681 687 12713883
122 Li Z Yang S Lin H Huang J Watkins PA Moser AB Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 2003 37 343 350 12540784
123 Sandler NG Koh C Roque A Eccleston JL Siegel RB Demino M Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection Gastroenterology 2011 141 1220 1230 1230.e1 1230.e3 21726511
124 Steib CJ Hartmann AC v Hesler C Benesic A Hennenberg M Bilzer M Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis Lab Invest 2010 90 1024 1032 20212458
125 Chiva M Guarner C Peralta C Llovet T Gómez G Soriano G Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats Eur J Gastroenterol Hepatol 2003 15 145 150 12560758
126 Clements WD Erwin P McCaigue MD Halliday I Barclay GR Rowlands BJ Conclusive evidence of endotoxaemia in biliary obstruction Gut 1998 42 293 299 9536958
127 Wiest R Das S Cadelina G Garcia-Tsao G Milstien S Groszmann RJ Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility J Clin Invest 1999 104 1223 1233 10545521
128 Tazi KA Moreau R Hervé P Dauvergne A Cazals-Hatem D Bert F Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling Gastroenterology 2005 129 303 314 16012955
129 Seki E De Minicis S Osterreicher CH Kluwe J Osawa Y Brenner DA TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 2007 13 1324 1332 17952090
130 Huang H Shiffman ML Friedman S Venkatesh R Bzowej N Abar OT A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C Hepatology 2007 46 297 306 17461418
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.